A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice
出版年份 2019 全文链接
标题
A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-09-18
DOI
10.3389/fmicb.2019.02157
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Injectable Excipients as Novel Influenza Vaccine Adjuvants
- (2019) Huapeng Feng et al. Frontiers in Microbiology
- Current and future influenza vaccines
- (2019) Seiya Yamayoshi et al. NATURE MEDICINE
- Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
- (2018) Daniela S. Rajão et al. Frontiers in Microbiology
- Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
- (2018) Brendan Flannery et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The Effectiveness of Influenza Vaccination in Different Groups
- (2016) Angela Domínguez et al. Expert Review of Vaccines
- Least-Squares Means: TheRPackagelsmeans
- (2016) Russell V. Lenth Journal of Statistical Software
- Adjuvant effects of invariant NKT cell ligand potentiates the innate and adaptive immunity to an inactivated H1N1 swine influenza virus vaccine in pigs
- (2016) Varun Dwivedi et al. VETERINARY MICROBIOLOGY
- OASIS 2: online application for survival analysis 2 with features for the analysis of maximal lifespan and healthspan in aging research
- (2016) Seong Kyu Han et al. Oncotarget
- α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant
- (2016) Bianca L. Artiaga et al. Scientific Reports
- Influenza Vaccines: Challenges and Solutions
- (2015) Katherine Houser et al. Cell Host & Microbe
- Fitting Linear Mixed-Effects Models Usinglme4
- (2015) Douglas Bates et al. Journal of Statistical Software
- Suboptimal Effectiveness of the 2011–2012 Seasonal Influenza Vaccine in Adult Korean Populations
- (2015) Won Suk Choi et al. PLoS One
- Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus
- (2014) Jung-Tung Hung et al. ANTIVIRAL RESEARCH
- Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii
- (2014) Gang Lu et al. BMC INFECTIOUS DISEASES
- Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine
- (2014) Ryuta Uraki et al. VACCINE
- Toward a Universal Influenza Virus Vaccine: Prospects and Challenges
- (2013) Natalie Pica et al. Annual Review of Medicine
- A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+ T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates
- (2013) Neal N. Padte et al. PLoS One
- Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer
- (2013) Y.-L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells
- (2012) Enrico Girardi et al. IMMUNOLOGICAL REVIEWS
- Adjuvants in influenza vaccines
- (2012) Kohhei Tetsutani et al. VACCINE
- Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly
- (2012) Roberto Gasparini et al. Human Vaccines & Immunotherapeutics
- Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of -GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
- (2011) A. J. Nicol et al. CLINICAL CANCER RESEARCH
- Neonatal immunization: where do we stand?
- (2011) Nicholas Wood et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Preclinical efficacy studies of influenza A haemagglutinin precursor cleavage loop peptides as a potential vaccine
- (2011) D. S. Miller et al. JOURNAL OF GENERAL VIROLOGY
- Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice
- (2011) Saori Sakabe et al. VIRUS RESEARCH
- Vaccine adjuvants – Current status and prospects on controlled release adjuvancity
- (2011) S.M. Sivakumar et al. SAUDI PHARMACEUTICAL JOURNAL
- New adjuvants for human vaccines
- (2010) M Lamine Mbow et al. CURRENT OPINION IN IMMUNOLOGY
- Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant
- (2010) X. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
- (2010) Daejin Kim et al. VACCINE
- An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine
- (2010) Yoon-Sook Lee et al. VACCINE
- Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity
- (2009) C. Guillonneau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine
- (2009) Sarah A. Kopecky-Bromberg et al. VACCINE
- Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses
- (2008) H Kamijuku et al. Mucosal Immunology
- α-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors
- (2008) Youn Seok Choi et al. VACCINE
- Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide
- (2008) Yaoxing Huang et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now